Abstract |
Sodium o-iodobenzoate ( OISB) produces an increase in P50 (PO2 at 50% of oxyhemoglobin saturation) and survival when infused at the time of initiation of prolonged hemorrhagic shock in dogs. Acid-base parameters improved during treatment, and plasma lactic acid concentrations showed smaller rises than in nontreated control animals. Erythrocyte 2,3-diphosphoglycerate (2,3-DPG) rose in prolonged hemorrhagic shock in the control group and conversely decreased in OISB-treated dogs. OISB did not require red cell integrity, since its effects were still more marked in hemolyzed blood. The therapeutic benefit of OISB, appears to be related to a direct effect of the agent on the hemoglobin molecule.
|
Authors | C F Bercovich, C J Pirola, S Finkielman, V E Nahmod |
Journal | Circulatory shock
(Circ Shock)
Vol. 33
Issue 2
Pg. 63-7
(Feb 1991)
ISSN: 0092-6213 [Print] United States |
PMID | 2049815
(Publication Type: Journal Article)
|
Chemical References |
- Bicarbonates
- Diphosphoglyceric Acids
- Iodobenzoates
- Lactates
- 2,3-Diphosphoglycerate
- Lactic Acid
- 2-iodobenzoic acid
- Oxygen
|
Topics |
- 2,3-Diphosphoglycerate
- Acidosis
(drug therapy, etiology)
- Animals
- Bicarbonates
(blood)
- Diphosphoglyceric Acids
(blood)
- Dogs
- Erythrocytes
(metabolism)
- Female
- Iodobenzoates
(therapeutic use)
- Lactates
(blood)
- Lactic Acid
- Male
- Oxygen
(blood)
- Shock, Hemorrhagic
(blood, complications, drug therapy)
|